| Mrs Jennifer Leigh Place, OD | |
|
2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302-0950 | |
| (248) 258-9000 | |
| (248) 499-6372 |
| Full Name | Mrs Jennifer Leigh Place |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 2550 S Telegraph Rd, Bloomfield Hills, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982727111 | NPI | - | NPPES |
| 0E04240 | Other | MI | BLUE CROSS |
| JP004123 | Other | MI | BLUE CROSS BLUE SHIELD |
| 1GV09539 | Other | MI | CIGAN HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 5330000086 (Michigan) | Primary |
| 152WC0802X | Optometrist - Corneal And Contact Management | 4901004123 (Michigan) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vision Specialists Of Birmingham, Pllc | 0244209468 | 6 |
News Archive
C. R. Bard, Inc. today announced the publication of trial results by The New England Journal of Medicine (NEJM) showing the Bard FLAIR® Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone. The FLAIR® Endovascular Stent Graft is the only implant approved by the U.S. Food and Drug Administration for use in the treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous access grafts.
Enobia Pharma Inc. unveiled findings from the first hypophosphatasia self-reported patient survey intended to evaluate the burden of illness associated with HPP at the 2010 American College of Medical Genetics Annual Clinical Genetics Meeting.
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
Two large studies from Northwestern Medicine confirm a healthy lifestyle has the biggest impact on cardiovascular health. One study shows the majority of people who adopted healthy lifestyle behaviors in young adulthood maintained a low cardiovascular risk profile in middle age.
› Verified 8 days ago
| Provider Name | Vision Specialists Of Birmingham, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356488597 PECOS PAC ID: 0244209468 Enrollment ID: O20040924000916 |
News Archive
C. R. Bard, Inc. today announced the publication of trial results by The New England Journal of Medicine (NEJM) showing the Bard FLAIR® Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone. The FLAIR® Endovascular Stent Graft is the only implant approved by the U.S. Food and Drug Administration for use in the treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous access grafts.
Enobia Pharma Inc. unveiled findings from the first hypophosphatasia self-reported patient survey intended to evaluate the burden of illness associated with HPP at the 2010 American College of Medical Genetics Annual Clinical Genetics Meeting.
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
Two large studies from Northwestern Medicine confirm a healthy lifestyle has the biggest impact on cardiovascular health. One study shows the majority of people who adopted healthy lifestyle behaviors in young adulthood maintained a low cardiovascular risk profile in middle age.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jennifer Leigh Place, OD 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302-0950 Ph: (248) 258-9000 | Mrs Jennifer Leigh Place, OD 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302-0950 Ph: (248) 258-9000 |
News Archive
C. R. Bard, Inc. today announced the publication of trial results by The New England Journal of Medicine (NEJM) showing the Bard FLAIR® Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone. The FLAIR® Endovascular Stent Graft is the only implant approved by the U.S. Food and Drug Administration for use in the treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous access grafts.
Enobia Pharma Inc. unveiled findings from the first hypophosphatasia self-reported patient survey intended to evaluate the burden of illness associated with HPP at the 2010 American College of Medical Genetics Annual Clinical Genetics Meeting.
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
Two large studies from Northwestern Medicine confirm a healthy lifestyle has the biggest impact on cardiovascular health. One study shows the majority of people who adopted healthy lifestyle behaviors in young adulthood maintained a low cardiovascular risk profile in middle age.
› Verified 8 days ago
Mrs. Maryjo Ference, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2550 S Telegraph Rd Ste 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Dr. Paul Charles Feinberg, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2550 S Telegraph Rd Ste 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Dr. Debra Lynn Feinberg, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-6372 | |
Eliza Seros, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4114 W Maple Rd, Bloomfield Hills, MI 48301 Phone: 248-539-4800 | |
Dr. Michael S Weishaus, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6523 Telegraph Rd, Bloomfield Hills, MI 48301 Phone: 248-593-9955 Fax: 248-593-9966 | |
Vision Specialists Of Michigan Optometrist Medicare: Medicare Enrolled Practice Location: 2550 S Telegraph Rd, Suite 100, Bloomfield Hills, MI 48302 Phone: 248-258-9000 Fax: 248-499-7362 | |
Dr. Kevin Semma, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 3683 W Maple Rd, Bloomfield Hills, MI 48301 Phone: 248-246-4466 |